In 2019, Han et al. demonstrated that MYC induces immunogenic cell death of tumor cells, which leads to increased T cell infiltration and upregulation of the PD-L1 immune checkpoint protein in the TME [73]. The gene discussed is CD274; the disease is neoplasm.